Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Prepaid Assets (2023 - 2025)

Historic Prepaid Assets for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $6.5 million.

  • Artiva Biotherapeutics' Prepaid Assets rose 10034.02% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 10034.02%. This contributed to the annual value of $3.1 million for FY2024, which is 17994.51% up from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Prepaid Assets of $6.5 million as of Q3 2025, which was up 10034.02% from $6.7 million recorded in Q2 2025.
  • Artiva Biotherapeutics' Prepaid Assets' 5-year high stood at $6.7 million during Q2 2025, with a 5-year trough of $1.1 million in Q4 2023.
  • Its 3-year average for Prepaid Assets is $3.7 million, with a median of $3.2 million in 2024.
  • Over the last 5 years, Artiva Biotherapeutics' Prepaid Assets had its largest YoY gain of 28516.17% in 2025, and its largest YoY loss of 10034.02% in 2025.
  • Over the past 3 years, Artiva Biotherapeutics' Prepaid Assets (Quarter) stood at $1.1 million in 2023, then soared by 179.95% to $3.1 million in 2024, then soared by 111.87% to $6.5 million in 2025.
  • Its Prepaid Assets stands at $6.5 million for Q3 2025, versus $6.7 million for Q2 2025 and $3.8 million for Q1 2025.